MENU
+Compare
TRML
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$16.54
Change
-$0.17 (-1.02%)
Capitalization
425.14M

TRML Tourmaline Bio Forecast, Technical & Fundamental Analysis

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases... Show more

TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for TRML with price predictions
Jun 27, 2025

TRML in upward trend: 10-day moving average broke above 50-day moving average on May 23, 2025

The 10-day moving average for TRML crossed bullishly above the 50-day moving average on May 23, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where TRML advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day RSI Indicator for TRML moved out of overbought territory on June 16, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on June 17, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on TRML as a result. In of 71 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for TRML turned negative on June 18, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

TRML moved below its 50-day moving average on June 26, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TRML declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

TRML broke above its upper Bollinger Band on June 03, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for TRML entered a downward trend on May 30, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.518) is normal, around the industry mean (16.345). P/E Ratio (0.000) is within average values for comparable stocks, (58.407). TRML's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.310). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (252.768).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. TRML’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TRML’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
TRML
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

TRML is expected to report earnings to fall 77.53% to -20 cents per share on August 10

Tourmaline Bio TRML Stock Earnings Reports
Q2'23
Est.
$-0.20
Q1'25
Missed
by $0.03
Q4'24
Missed
by $0.25
Q1'23
Beat
by $0.09
Q4'22
Missed
by $4.71
The last earnings report on May 02 showed earnings per share of -88 cents, missing the estimate of -86 cents. With 529.93K shares outstanding, the current market capitalization sits at 425.14M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
27 West 24th Street
Phone
+1 646 481-9832
Employees
44
Web
https://www.tourmalinebio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ILGJX22.800.16
+0.71%
Columbia Integrated Large Cap Gr Ins 3
OCLVX19.350.09
+0.47%
Optimum Large Cap Value C
DHLRX33.520.14
+0.42%
Diamond Hill Large Cap I
AXVNX17.650.06
+0.34%
Acclivity Small Cap Value N
NOSGX12.770.01
+0.08%
Northern Small Cap Value

TRML and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, TRML has been closely correlated with SPHDF. These tickers have moved in lockstep 78% of the time. This A.I.-generated data suggests there is a high statistical probability that if TRML jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRML
1D Price
Change %
TRML100%
-1.02%
SPHDF - TRML
78%
Closely correlated
N/A
IMNM - TRML
51%
Loosely correlated
-0.23%
STOK - TRML
48%
Loosely correlated
-1.77%
IPSC - TRML
45%
Loosely correlated
-5.74%
SYRE - TRML
45%
Loosely correlated
-4.99%
More